Companies /Healthcare

Tactile Systems Technology Inc

NASDAQ: TCMD Medical Devices
$26.37
▼ $0.44 (−1.64%) today
Markets closed · 3:55am ET

TCMD at a Glance

Valuation
Market cap
$600.6M
P/E ratio
26.0
Profitability
Revenue (TTM)
$356.4M
Profit margin
6.7%
EPS (TTM)
$1.03
Price
52-week range
$21 – $38
Street target
$36.33
Earnings
Next report
Feb 16, 2027

Headquartered in Minneapolis, MN Fiscal year ends December NASDAQ: TCMD tactilemedical.com

About Tactile Systems Technology

Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company. It develops and markets at-home therapies for people with underserved chronic conditions, including lymphedema, lipedema, chronic venous insufficiency and chronic respiratory conditions.

Its business has two product lines:
- **Lymphedema products** (89% of Q3 2026 revenue): basic and advanced pneumatic compression systems, including the Flexitouch system, plus the LymphaTech 3D Scanner. The scanner recently received an expanded FDA clearance to aid in assessing lymphedema.
- **Airway clearance products**: the AffloVest high-frequency chest wall oscillation vest, whose next-generation system launched in Q2 2026.

The company generates both sales and rental revenue and relies on reimbursement from third-party payers. It sells through direct and DME channels. It works with clinicians to expand clinical evidence, raise awareness and increase access to care.

The company has a pending 510(k) submission for Flexitouch Pro. It completed an acquisition in 2026 and has no outstanding borrowings under its credit agreement. Updated

Latest Activity

TCMDTactile Systems Technology
Q3 2026
EPS
$0.31
est $0.34-7.5%
Revenue
$92M
est $92M-0.1%

A 25% drop in airway clearance revenue, tied to a distributor inventory transition around the new AffloVest, pushed Tactile Medical below expectations on both lines. Management reaffirmed full-year revenue guidance and raised its adjusted EBITDA outlook, framing the shortfall as timing.

Quarterly EPS — reported vs estimate

TCMD Coverage

Frequently Asked Questions

What does Tactile Systems Technology do?

Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company. It develops and markets at-home therapies for people with underserved chronic conditions, including lymphedema, lipedema, chronic venous insufficiency and chronic respiratory conditions.

What is the TCMD stock price target?

The Wall Street consensus 12-month price target for TCMD is $36.33.